ArticleJournal of translational medicine2024

CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1.

Yiquan Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.